Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

[25] Shaamash et al. [27] conducted a prospective, controlled, randomized trial (n = 320) comparing the levonorgestrel-20 µg intrauterine system Mirena (Bayer HealthCare Pharmaceuticals ...